Matrix-degrading metalloproteinases may play a role in the pathophysiology of bronchopulmonary dysplasia (BDP). We therefore evaluated correlations between gelatinase activities (Metalloproteinase (MMP)-2 and MMP-9) or tissue inhibitor of metalloproteinase (TIMP)-1 levels present in the airways during the initial phase of hyaline membrane disease and the onset of BPD. Tracheal aspirates were obtained within 6 hours of birth (day 0) from 64 intubated neonates with a gestational age of 30 weeks or less. Forty-five neonates were resampled on day 3 or day 5. Total MMP-2 level measured by zymography fell with time, whereas total MMP-9 level and TIMP-1 levels, assayed by ELISA, increased; the MMP-9 increase correlated with the increase in airway inflammatory cell numbers. Among the parameters measured on day 0, day 3, or day 5, lower total MMP-2 level on day 0, lower birth weight and higher FiO2 on day 0 were significantly and independently associated with the development of BPD.
INTRODUCTION
Premature neonates with hyaline membrane disease are at risk of developing bronchopulmonary dysplasia (BPD), as a sequel of both the disease and its treatment. The pathogenesis is unclear, but BPD is thought to result from damage to an immature lung.
Mechanical ventilation, oxygen therapy and airway inflammatory responses have all been implicated in the development of BPD (19) . These insults appear to interfere with normal lung maturation, which is incomplete at birth. In particular, they appear to alter alveolar formation, on the basis of morphometric studies of severe BPD (3, 24) . Alveolar formation is characterized by the multiplication of alveolar septa and the thinning of interalveolar walls, both of which require intense remodeling of the pulmonary extracellular matrix (4) . Changes in matrix turnover have been experimentally linked to abnormal alveolar formation (20) . The proteinase-antiproteinase balance in the lung is a key factor in harmonious matrix turnover. In particular, matrix metalloproteinases (MMPs), which can synergistically digest the major macromolecules of connective tissue matrices, have been implicated in physiological regulation of lung growth. The MMP gelatinase A (MMP-2) has been shown to play a role in the major collagen turnover that occurs during early postnatal rat lung growth (1, 2) . We postulated that MMP-2 might also participate in human lung development, and that inadequate MMP-2 levels in premature lungs exposed to insults could contribute to impaired lung growth and, thus, to BPD. We also postulated that MMPs may be secreted in excess during the inflammatory response associated with hyaline membrane disease, and may therefore lead to tissue degradation. Gelatinase B (MMP-9) is the main MMP released by inflammatory cells such as neutrophils and alveolar macrophages (17, 35) , and has been implicated in human lung diseases such as cystic fibrosis (11) and asthma (22) . We thus studied premature infants with hyaline membrane disease to determine whether the profile of Gelatinase activities at birth was associated with the subsequent risk of BPD, and to examine Final accepted version -LCMP-00066-2002.R1 -2 the possible link between the early postnatal time course of gelatinase activities and clinical outcome. We also tested airway secretions for tissue inhibitor of metalloproteinases-1 (TIMP-1), a key specific inhibitor of matrix metalloproteineases that forms tight complexes with activated MMP-2 and MMP-9 (26, 36) .
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PATIENTS AND METHODS
Reagents
All reagents were obtained from Sigma Chemical (St. Louis, MO) unless otherwise specified.
Study design
We measured MMP-2, MMP-9 and TIMP-1 levels in airway secretions of highly premature neonates with recent-onset hyaline membrane disease, and tested their correlation with clinical outcome. Tracheal aspirates were obtained from intubated premature neonates within 6 hours of birth (day 0), before surfactant instillation. This first sample was considered to reflect physiological metalloproteinase activity. Infants still intubated on day 3 and day 5 were resampled. Changes in MMP-2, MMP-9, or TIMP-1 activities between day 0 and day 3 or day 5 were considered to reflect the airway response to insults. This study was part of a clinical research program (PHRC) approved by the local ethics committee, and the parents' informed consent was obtained.
Study group
Sixty-four neonates with gestational age of 30 weeks or less were included in the study from February 97 to February 99. They all had clinical and radiological diagnostic criteria of hyaline membrane disease. Infants suspected to be born after chorioamniotis or having maternofetal infection were excluded from the study. The mean term was 27.8 ± 0.2 (SEM) weeks (range 24 to 30 weeks), and mean birth weight was 994 ± 28 g (600 to 1540 g). Only one of the neonates had intrauterine growth retardation. Corticosteroids had been administered to the mother in 33 cases. Forty-five neonates required prolonged mechanical ventilation and were resampled on day 3 or day 5.
Final accepted version -LCMP-00066-2002.R1 -4
Peak inspiratory pressure (Ppi) and the fraction of inspired oxygen (FiO2) were noted just before tracheal aspiration. The diagnosis of BPD was based on the continued need for oxygen supplementation at a postconceptional age (PCA) of 36 weeks (31) .
Collection of tracheal secretions
Gentle tracheal aspiration is routinely performed in our unit to maintain airway patency in intubated neonates. These aspirates were the samples used for this study. Suction was preceded by instillation of 0.2 ml of isotonic saline. After three to five ventilator breaths, suctioning was performed through a small catheter and the aspirated material was collected in an Infant Mucus Extractor (Vygon, Ecouen, France). It was then diluted in 0.2 ml isotonic saline, gently vortexed, and centrifuged at 1200 rpm and 4°C for 10 min. The supernatant was recovered (mean volume: 190 ± 12 µl ) and stored at -80°C. The cell pellet was resuspended in 0.2 ml of 0.1% dithiothreitol. Cell smears were stained with the standard May-Grünwald-Giemsa procedure and differential cell counts were done. This technique was very close from others previously described (15, 32) . Although some authors used higher aliquot volumes and higher aliquot numbers, it concerned studies with neonates with higher gestational age and higher birth weight than in our population (9, 16) . In our experience, higher aliquot volumes were badly tolerated in numerous premature weighing less than 1,000 g. Because of the small volume of saline instilled into the airways, the dilution factor induced by our technique was thought to be low and was evaluated in preliminary experiments, using secretory IgA (sIgA) as a dilution marker (Immun Diagnostik, Bensheim, Germany). The inter-subject coefficient of variation of sIgA in 60 samples was 18.2%, demonstrating a much lower variability in the dilution factor than that observed with higher aliquot volumes (9) . Furthermore, we previously demonstrated with this method a high correlation between expression of results per ml of supernatant and per ng of sIgA (r=0.823 ; p < 0.0001) (8). Thus, the dilution factor induced by our method is low and does not introduce significant bias in results expressed per Final accepted version -LCMP-00066-2002.R1 -5 ml of supernatant. Given the fact that the small volume of sample recovered after aspiration do not allow to systematically measure sIgA in addition to other parameters, results were expressed per ml of supernatant.
Zymographic gelatinase analysis
Supernatants of tracheal aspirates were analyzed by electrophoresis in 11% (wt/vol) polyacrylamide gels containing 1 mg/ml gelatin in the presence of sodium dodecyl sulfate (SDS) in non reducing conditions. After electrophoresis, gels were washed in Triton X-100 2.5% for 1 h, then rinsed briefly and incubated at 37°C for 48 h in buffer containing 100 mM Tris-HCl, pH 7.40, and 10 mM CaCl 2 . The gels were then stained with Coomassie brillant blue R250 and restained in a solution of 7.5% acetic acid and 5% methanol. Zones of enzyme activity were indicated by negative staining; areas of proteolysis were seen as clear bands showed intra-gel and inter-gel coefficients of variation less than 10%. Total MMP-2 level was calculated as the sum of activities measured at 72 kDa (proenzyme) and 68 kDa (activated enzyme). Similarly, total MMP-9 level was calculated as the sum of activities measured at 92
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Immunoblotting
The 72-kDa and 92-kDa gelatinase activities were characterized by immunoblotting.
Supernatants of tracheal aspirates from five infants were pooled and partially purified by using gelatin-Sepharose chromatography as previously described (11). Samples were separated by SDS-PAGE and were electrophoretically transferred to nitrocellulose. After saturation of excess protein binding sites with 5% cow's milk in 0.05 M Tris-HCl and 0.15 M NaCl, pH 7.6 (Tris-buffered saline) for 1 h at room temperature, the nitrocellulose was incubated with a specific rabbit antibody to human 92-kDa MMP-2t 1:1,000 dilution (Clinisciences, Montrouge, France) or to human 72-kDa MMP-2t 1:5,000 dilution (Chemicon Inc, Temecula CA, USA) in the above buffer for 1 h at room temperature. After thorough washing with Tris-buffered saline, the samples were incubated with a peroxidase-labeled swine anti-rabbit antibody (1:1,000 dilution) in Tris-buffered saline containing 5% cow's milk for 1 h at room temperature. After washing, the immunoblots were visualized using an enhanced chemiluminescence detection kit (Amersham, Buckinghamshire, UK).
Free gelatinolytic activity
Gelatinolytic activity was assayed using [ micrograms of gelatin hydrolyzed per 48 h per ml of tracheal aspirate at 37°C. Controls for spontaneous degradation of the radiolabeled substrate were run in physiological saline.
TIMP-1 assay
Detection of human TIMP-1 was carried out on tracheal aspirate supernatants, using a selective ELISA system (TIMP-1, human ELISA system, Amersham Pharmacia Biotech).
Data analysis
All population data are expressed as means ± SEM.
Because MMP-2, MMP-9, and TIMP-1 levels were not normally distributed, we expressed each level as the median, 25 th to 75 th percentiles, and 10 th to 90 th percentiles. Data were normalized by log transformation for statistical analysis.
Results obtained at day 0 were first analyzed. The influence of gestational age and birth weight on enzyme activities was evaluated by using multivariate regression analysis, with the former parameters as independent variables and MMP-2, MMP-9 and TIMP-1 values as the dependent variables. Analysis of variance (ANOVA) was used to test the influence of maternal corticosteroid therapy. To identify early markers associated with higher risk for BPD, we used stepwise logistic regression analysis with BPD outcome as the dependent variable and all the parameters measured on day 0 (birth weight, gestational age, maternal corticosteroids, FiO2, Ppi, total MMP-2, total MMP-9, fraction of activated MMP-2 and -9, and TIMP-1) as independent variables.
A second analysis was performed on data for serially sampled neonates. Changes in gelatinase activities or TIMP-1 levels over time were assessed by ANOVA, followed by Fisher's PLSD test. Two-factor ANOVA analysis was used to evaluate differences in the pattern of change with time according to BPD outcome. To identify markers associated with higher risk for BPD, we used another stepwise logistic regression analysis with BPD outcome as the 
RESULTS
Gelatinase activities and TIMP-1 levels in airway secretions at birth
Sixty-four children were sampled within six hours of birth. Nine of these neonates died before reaching a postconceptional age of 36 weeks. Eighteen of the 55 survivors still needed oxygen supplementation at 36 weeks PCA and were thus considered to have BPD.
Various zymographic profiles of total gelatinase activity were observed according to the degree of prematurity and postnatal age ( Figure 1 ). These activities were identified as metalloproteinases, as they were completely inhibited by 10 mM EDTA but not by 2 mM PMSF or 2 mM N-ethylmaleimide. Immunoblotting with anti-human MMP-9 and anti-human MMP-2 antibodies identified the relevant metalloproteinases ( Figure 1 ). MMP-2 was the predominant form on day 0, while MMP-9 levels were low. Median values are reported in Table 1 . Activated MMP-2 (68-kD band) was observed in some neonates, contrary to activated MMP-9 (88-kD band). Very low levels of free gelatinolytic activity were found in most neonates.
Both birth weight and gestational age significantly influenced values on day 0, but multivariate regression analysis showed that birth weight was the main factor. Birth weight significantly influenced total MMP-9 level and the fraction of activated MMP-2, but not total MMP-2 level or the TIMP-1 level. The neonates with the lowest birth weights were characterized by very low MMP-9 level on day 0 (r= 0.42 ; p = 0.0005) and by a small fraction of activated MMP-2 (r=0.40 ; p = 0.001).
Median MMP-9 level (25 th to 75 th percentile) was significantly lower in neonates exposed to antenatal corticosteroids than in those unexposed: 0.4 (0.2 to 1.0) vs 1.0 (0.6 to 1.6) x10 5 AU/µl/48h, respectively (p < 0.05). MMP-2 levels were not significantly influenced by steroid exposure: 1.6 (0.6 to 2.8) vs 1.6 (1.1 to 2.7) x10 5 AU/µl/48h, respectively. (Table 2) Forty-five neonates were resampled on day 3, and 36 were sampled a third time on day 5.
They did not differ significantly on day 0 from the 19 neonates who were not resampled, except for FiO2 (0.54 ± 0.03 versus 0.41 ± 0.05, respectively; p<0.05). Fourteen of these 45
neonates still required oxygen supplementation at 36 weeks PCA.
Changes in measured parameters for these 45 neonates are summarized Table 2 
Inflammatory cells in tracheal aspirates
Differential cell counts were interpretable in 25 neonates. Very few inflammatory cells were observed on day 0 (median: 20 x 10 3 /ml (10 to 30)), and most were macrophages. Except in one child, no neutrophils were found on day 0. The median number of inflammatory cells increased on day 3 and day 5, to 100 (45 to 230) and 75 (50 to 108) x 10 3 /ml, respectively.
This increase was essentially due to recruitment of neutrophils, which represented 73.5 (65 to 79.5) and 52.5 (38 to 66) % of all inflammatory cells on day 3 and day 5, respectively.
The number of inflammatory cells correlated with total MMP-9 level (p < 0.05). Higher percentages of neutrophils were also associated with higher total MMP-9 level, but the correlation did not reach significance (p = 0.06). No significant relation was found between the inflammatory cell count and total MMP-2 level or TIMP-1 levels.
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DISCUSSION
The lungs undergo rapid remodeling during late gestation as a functional respiratory unit is formed. Premature birth may interfere with harmonious extracellular matrix turnover and is therefore associated with a high risk of alveolar disorders. Matrix-degrading metalloproteinases are key regulators of lung remodeling.
In this study of premature neonates at a high risk of chronic lung disease, we measured gelatinase activities in airway secretions early in the course of hyaline membrane disease.
These activities were then interpreted according to clinical outcome, focusing on subsequent development of BPD. We found that hyaline membrane disease was associated with an increase in MMP-9 level, the latter correlating with inflammatory cell recruitment to the airways; the increase in MMP-9 level was however not associated with subsequent onset of BPD. By contrast, low MMP-2 level was associated with later BPD onset, suggesting that MMP-2 level is essential for lung development and/or pulmonary tissue repair.
MMP-9 is a metalloproteinase secreted by a wide variety of cell types. In the lung, MMP-9 is synthesized by normal resident structural and inflammatory cells such as bronchial epithelial cells (37), alveolar epithelial cells (12, 28) , and alveolar macrophages (35). All these cell types can greatly increase their MMP-9 secretion after stimulation (12, 28, 35, 37).
Furthermore, neutrophils recruited into alveoli during lung injury can also secrete large amounts of MMP-9 (17) . MMP-9 has beneficial roles such as cell spreading and migration during repair of the respiratory epithelium (21) . However, most studies have focused on the potential deleterious effect of an imbalance between MMP-9 and TIMP induced by insults, and MMP-9 has been implicated in the pathogenesis of inflammatory airway diseases, such as cystic fibrosis (11), chronic bronchitis (33) and asthma (22, 33) .
Our study provides evidence of MMP-9 level in the airways of premature neonates with hyaline membrane disease. Immediately after birth, MMP-9 levels were strongly influenced
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by the degree of prematurity, suggesting that maturation processes regulate the capacity of resident lung cells to secrete MMP-9. We had previously found that spontaneous MMP-9 secretion by alveolar macrophages in newborn rats significantly varied with the lung growth phase (10). The number of alveolar macrophages is expected to be very low in premature neonates (10, 38), as confirmed here, and this may also contribute to the lower MMP-9 levels observed with increasing prematurity. Hyaline membrane disease was associated with increased MMP-9 level in the airways on day 3 and day 5 of life; this level correlated with the number of inflammatory cells, suggesting that MMP-9 mainly originated from recruited activated alveolar macrophages and neutrophils. In very premature neonates, the initially low MMP-9 activities increased on day 3 or day 5, reaching levels at least as high as those observed in less premature infants, arguing for a similar ability to respond to lung injury.
Once secreted, MMP-9 can be activated by many products present in inflammatory airways, especially oxidants (29) , and neutrophil elastase (34). In our study, the presence and amount of activated MMP-9 were not related to BPD outcome. Thus, MMP-9 may be considered as an important marker of the initial inflammatory response, but its contribution to the development of long-term sequel is uncertain. These findings are in complete agreement with our recent experiments performed in newborn rats (14) . Indeed, we found that alveolar growth disorders induced by intratracheal instillation of lipopolysaccharide were associated to alveolar neutrophil influx and increased MMP-9 level, but we failed to prevent growth disorders by inhibiting MMP-9 activity. Thus, in newborn rats as human preterm infants, no causal link could be established between MMP-9 overactivity induced by inflammatory processes and lung growth disorders.
MMP-2 detected in tracheal aspirate supernatants may originate from several cell types.
Fibroblasts are usually considered as the main source of MMP-2 (27) . Alveolar epithelial cells Maturation processes may, however, influence MMP-2 activation mechanisms, as the fraction of total MMP-2 level accounted for by the activated form increased in neonates with higher gestational ages and birth weights. Experiments with mouse skin fibroblasts have also shown that MMP-2 spontaneously secreted by adult fibroblasts is partially activated, contrary to that secreted by fetal or neonatal cells (18) . In contrast to MMP-9, MMP-2 level fell with time, and no correlation was found between MMP-2 levels and inflammatory cell counts, suggesting that lung insults and inflammatory airway responses do not stimulate MMP-2 secretion. However, this decrease with time must be interpreted with care, as it was observed in repeatedly sampled neonates, who had the most severe hyaline membrane disease, i.e. requiring at least 3 or 5 days of mechanical ventilation. For obvious reasons, control samples could not be obtained from neonates weaned from the ventilator before day 3. Changes in MMP-2 level with time could therefore reflect either a decreased activity induced by injury, potentially interfering with lung development and/or repair, or a physiological transient increase activity induced by birth, as suggested by experiments in rats showing that lung type IV collagenase mRNA expression and type IV collagenolytic activity are highest prior to birth (23) . The lack of MMP-2 activity in bronchial lavage fluid in healthy adults and patients with status asthmaticus (22) underline the specificity of MMP-2 profiles during the neonatal period were associated to greater areas of pericellular proteolysis in the underlying substrate (13) .
Although the reasons for this low MMP-2 level were not explored here, the very early occurrence of this profile after birth points to an intrinsic impairment. Such premature neonates may thus be unable to ensure normal lung development when faced with external insults.
TIMP-1 levels in our population were not associated with the initial severity of hyaline membrane disease or with the risk of BPD. TIMP-1 is a well-characterized specific inhibitor of matrix metalloproteinases. It interacts non covalently with active metalloproteinases, including MMP-2 and MMP-9, and also binds to the pro form of MMP-9, thus regulating its
Final accepted version -LCMP-00066-2002. R1 -16 activation (26, 36) . It is secreted by a wide variety of cell types, including lung epithelial cells, fibroblasts, alveolar macrophages and neutrophils. Measurement of TIMP-2 levels might also be of value, as TIMP-2 also binds specifically to pro form of MMP-2 and participates in the regulation of MMP-2 activation. Unfortunately, most samples collected in our study were too small for TIMP-2 assay. During lung development, TIMP-1 mRNA expression in baboons (25) was low during fetal development but underwent a marked increase in the lung shortly after both premature and term birth. Our results are in keeping with this study, showing a postnatal increase in TIMP-1 levels in the airways, independently of gestational age. The coincident increases in TIMP-1 and MMP-9 levels may strongly contribute to the fact that activated MMP-9 was present at day 3 or day 5 only in a minority of infants.
In conclusion, both MMP-2 and MMP-9 activities were found in airways of premature neonates with hyaline membrane disease. However, clear differences were found between these two metalloproteinases, regarding the influence of birth weight, changes induced by lung insult, and their role in the subsequent onset of bronchopulmonary dysplasia. MMP-9 level was influenced by birth weight and the inflammatory response to lung insult. No association was found with subsequent respiratory outcome. In contrast, MMP-2 level was independent of birth weight and the local inflammatory response. Low MMP-2 level was strongly associated with subsequent onset of bronchopulmonary dysplasia. from neonates repeatedly sampled on day 0, day 3 and day 5 of life. The fraction of activated gelatinase is calculated as the ratio of the active form to the sum of the active and pro forms. * p < 0.05 compared to day 0 ; § p < 0.05 compared to BPD-.
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